|
Volumn 39, Issue 2, 2008, Pages 433-438
|
Intravenous rosuvastatin for acute stroke treatment: An animal study
|
Author keywords
Cerebral ischemia; HMG CoA reductase inhibitors; Neuroprotection; Statins
|
Indexed keywords
NITRIC OXIDE SYNTHASE;
PROTEIN KINASE B;
ROSUVASTATIN;
FLUOROBENZENE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INDUCIBLE NITRIC OXIDE SYNTHASE;
NOS3 PROTEIN, MOUSE;
PYRIMIDINE DERIVATIVE;
SULFONAMIDE;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BRAIN ISCHEMIA;
CONTROLLED STUDY;
MAXIMUM PLASMA CONCENTRATION;
MIDDLE CEREBRAL ARTERY OCCLUSION;
MOUSE;
MOUSE STRAIN;
MOUSE STRAIN 129/SV;
NEUROPROTECTION;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
REPERFUSION;
STROKE;
VASCULAR LESION;
VASCULARIZATION;
ACUTE DISEASE;
ANIMAL;
AORTA;
BLOOD;
CEREBRAL ARTERY DISEASE;
CONVALESCENCE;
DISEASE MODEL;
DOSE RESPONSE;
DRUG EFFECT;
ENZYMOLOGY;
INTRAVENOUS DRUG ADMINISTRATION;
METABOLISM;
PATHOLOGY;
PHOSPHORYLATION;
REPERFUSION INJURY;
ACUTE DISEASE;
ANIMALS;
AORTA;
DISEASE MODELS, ANIMAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FLUOROBENZENES;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
INFARCTION, MIDDLE CEREBRAL ARTERY;
INJECTIONS, INTRAVENOUS;
MICE;
MICE, INBRED STRAINS;
NITRIC OXIDE SYNTHASE TYPE II;
PHOSPHORYLATION;
PROTO-ONCOGENE PROTEINS C-AKT;
PYRIMIDINES;
RECOVERY OF FUNCTION;
REPERFUSION INJURY;
SULFONAMIDES;
|
EID: 39349090619
PISSN: 00392499
EISSN: None
Source Type: Journal
DOI: 10.1161/STROKEAHA.107.492470 Document Type: Article |
Times cited : (93)
|
References (15)
|